Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

Iland, H; Bradstock, K; Seymour, J; Hertzberg, M; Grigg, A; Taylor, K; Catalano, J; Cannell, P; Horvath, N; Deveridge, S; Browett, P; Brighton, T; Chong, L; Springall, F; Ayling, J; Catalano, A; Supple, S; Collins, M; Di, I; Reynolds, John

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

journal contribution

posted on 2012-02-01, 00:00 authored by H Iland, K Bradstock, J Seymour, M Hertzberg, A Grigg, K Taylor, J Catalano, P Cannell, N Horvath, S Deveridge, P Browett, T Brighton, L Chong, F Springall, J Ayling, A Catalano, S Supple, M Collins, I Di, John Reynolds

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

History

Journal

Haematologica

Volume

97

Pagination

227 - 234

Location

Pavia, Italy

Open access

Yes

Link to full text

https://doi.org/10.3324/haematol.2011.047506

ISSN

0390-6078

eISSN

1592-8721

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Usage metrics

Keywords

acute promyelocytic leukemia ATRA consolidation Idarubicin induction Australasian Leukaemia and Lymphoma Group

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

History

Journal

Volume

Pagination

Location

Open access

Link to full text

ISSN

eISSN

Language

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports